Obstructive sleep apnea patients adhere to positive airway pressure treatment just as well whether diagnosis and titration occur at home or in the sleep laboratory, researchers found.
__________

The application of new coverage determination adherence criteria for continued reimbursement of continuous positive airway pressure (CPAP) may have potential negative effects on patients with obstructive sleep apnea (OSA) and their clinical care. Adherence to therapy is defined as use of PAP more than four hours per night for at least 70 percent of [...]
Royal Philips Electronics today showcased the next generation Philips Respironics Sleep Therapy System at Medtrade 2009, a conference and expo for the home medical equipment industry.
The arrival of the new product line brings advances in sleep apnea therapy, the manufacturer says, that will benefit millions of sleep apnea sufferers, as well as bring new solutions to healthcare providers trying to meet today’s healthcare challenges.
Royal Philips Electronics launched a program aimed at the trucking industry with hopes of increasing awareness of obstructive sleep apnea (OSA), a potentially fatal sleep-breathing disorder that can negatively affect drivers and impact trucking companies.
Operated by Philips Respironics, the “Sleep Well, Drive Safe” program is designed to educate trucking company owners and create greater awareness of possible ways to reduce drowsy driving.
The Centers for Medicare & Medicaid Services (CMS) has expanded Medicare coverage for continuous positive airway pressure (CPAP) devices to include beneficiaries who have been diagnosed, using a home sleep test, with obstructive sleep apnea. CMS also announced changes to simplify certain test requirements.
Obstructive sleep apnea (OSA) is a condition characterized by the complete cessation of breathing for a period of at least 10 seconds (apnea) during sleep. In most instances, obstructive sleep apnea is diagnosed by counting the number of sleep disturbances that occur during a specific time interval. Up to four million Medicare beneficiaries may suffer from some form of obstructive sleep apnea.

A study recently published demonstrates that individuals diagnosed with obstructive sleep apnea (OSA) may have hope of regaining cognitive functions once they begin treatment for the apnea.
Study results, published in the December 2006 issue of CHEST, show the majority of trial participants who suffered memory-impairment prior to treatment demonstrated normal memory performance after three months of optimal continuous positive airway pressure CPAP use.
A CPAP is a medical device, which, in the simplest of terms, is an air generator set to deliver a prescribed, constant flow of air, keeping the airway open and preventing apnea.
As of May 2, 2009 at 9:47 p.m. (-0500) (ET), the U.S. population
was 306,340,710. Sleep researchers estimate approximately seven percent
of the population suffers from obstructive sleep apnea. Using that
estimate, there are potentially 21,443,850 apneics in the U.S.
~~ Apnea around the world ~~
As of May 2, 2009 at 9:47 p.m. (-0500) (ET), the world population
was 6,777,286,604. Sleep researchers estimate approximately seven percent
of the population suffers from obstructive sleep apnea. Using that
estimate, there are potentially 474,410,062 apneics in the world.